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The complete amino acid sequence of a thrombin-like nzyme with gyroxin activity isolated from the venom of the bushmaster snake La&e& mutu 
muta was determined by automated and DABITWPITC microsequencing of the intact protein; fragments derived from it by separate cleavages 
with cyanogen bromide, iodosobenzoic acid and hydroxylamine; and peptides resulting from enzymatic digestions with trypsin, pepsin, chymotryp- 
sin, and elastase. The protein, which is composed of 228 residues, contains four putative sites of N-linked glycosylation and exhibits significant 
sequence similarities with other serine proteases reported from snake venoms. 
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1. INTRODUCTION 
The bushmaster snake (Lachesis muta muta), a pit 
viper reaching lengths of 3 m, occurs in forested regions 
of equatorial Central and South America. Lachesis is 
believed to be ancestral to Agkistrodon and Crotulus [ 11. 
The venom of this crotalid snake which is notable for 
its haemorrhagic, proteolytic and blood-clotting activi- 
ties [2-51, contains a thrombin-like enzyme which has 
been purified by a combination of gel filtration on Se- 
phadex GlOO and affinity chromatography on Sepha- 
rose-agmatin [5]. The enzyme was shown to be a 
glycoprotein composed of a single polypeptide chain 
which existed in several isoelectric forms with pIs rang- 
ing from 3.1 to 5.0, but the asialoenzyme focused as a 
narrow band at pH 8.7. SDS-PAGE analysis gave a 
single broad band with an apparent M,, of 41-47kDa. 
The enzyme hydrolyzed synthetic substrates with a 
specificity similar to trypsin, was competitively inhib- 
ited by amidines and guanidines, and irreversibly inhib- 
ited by diisopropylfluorophosphate. The enzyme 
cleaved only fibrinopeptide A from fibrinogen, did not 
activate factor XIII and was devoid of kallikrein-like 
activity [5]. When injected into the tail veins of mice at 
levels of 0.015-O. 130 ,ug/g mouse, the thrombin-like en- 
zyme induced temporary episodes of opisthotonos and 
rapid rolling around the long axis of the animals [5,6]. 
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Thrombin-like enzymes which cause similar gyratory 
activity in test animals have been reported from a num- 
ber of other snake venoms. These include the so-called 
gyroxin from Crotulus durissus terrzjicus, crotalase from 
Crotalus adamanteus, and ancrod from Agkistrodon 
rhodostomu [7-91. 
We now report the complete primary structure of this 
neurotoxic enzyme and gyroxin analogue from L. muta 
muta and its sequence similarities with some other serine 
proteases from snake venoms. 
2. MATERIALS AND METHODS 
2.1. PuriJicution of thrombin-like enzyme 
The methods used for the collection and storage of venom and the 
purification of the thrombin-like nzyme by gel filtration on Sephadex 
G-100 and affinity chromatography on Sepharose-agmatine w re as 
described in [5]. 
2.2. Determination of amino ucid sequence 
2.2.1. Reduction and S-carboxymethylation 
The protein was reduced and S-carboxymethylated asdescribed in 
[lOI. 
2.2.2. Chemical cleavages 
Cleavage at methionine residues was achieved by treatment of a 
sample (3 mg) of the reduced and S-alkylated protein with cyanogen 
bromide (IOO-fold molar excess) in 2 ml of 70% formic acid under 
nitrogen for 48 h at 20°C. After lyophilization the residue was dis- 
solved in 1 ml of 0.1 M ammonium bicarbonate containing 6 M 
guanidine-HCl and fractionated on a column (1 x 200 cm) of Biogel 
P-6 in 0.1 M ammonium bicarbonate. Each fraction was further puri- 
fied by reverse phase HPLC on a column (25 cm x 4.6 mm) of yldac 
Cl 8 (218TP54, Technic01 Stockport) using a linear gradient of O-70% 
acetonitrile in 0.1% (v/v) aqueous trifluoroacetic acid. 
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Cleavage after tryptophan was obtained by treating a further sam- 
ple (5 mg) with 15 mg of o-iodosobenzoic acid in 2 ml of 80% acetic 
acid containing 4 M guanidine-HCI and 10 mol% p-cresol under nitro- 
gen at 22°C for 24 h in the dark as described in [1 11. The products were 
desalted and partially fractionated on a column (1 x 100 cm) of Bio-gel 
P30 in 70% formic acid before being further purified by RP-HPLC as 
described above. 
Cleavage of an asparagine-glycine peptide bond was carried out 
using 2 M hydroxylamine-HCl in 6 M guanidine-HCl maintained at 
pH 9.0 by the addition of 4.5 M LiOH during 4 h at 23°C as described 
in [1 11. Purification of the C-terminal fragment required for sequenc- 
ing was achieved by RP-HPLC. 
2.2.3. Enzymatic cleavages 
Samples (50-100 nmol) of the reduced and Salkylated protein were 
digested separately with trypsin (2% w/w enzyme/substrate in 0.1 M 
ammonium bicarbonate, pH 8.2, 4 h at 37”C), pepsin (1% w/w en- 
zyme/substrate in 5% formic acid, 2 h at 25”C), elastase (2% w/w 
enzyme/substrate in 0.1 M ammonium bicarbonate, pH 8.2, 3 h at 
37”C), and chymotrypsin (2% w/w enzyme/substrate in 0.2 M N- 
ethylmorpholine-HCl, pH 8.5, 2 h at 37°C). The peptides produced 
were purified by RP-HPLC. 
2.2.4. Sequence determination 
The N-terminal sequence of the intact reduced and Salkylated 
protein (5 nmol) was determined by automatic sequencing in an Ap- 
plied Biosystems Model 477A pulsed liquid phase Sequencer/Model 
120A PTH HPLC analyzer system using a standard Edman degrada- 
tion programme. The larger fragments resulting from the chemical 
cleavages with cyanogen bromide, iodosobenzoic acid and hydroxyl- 
amine were sequenced by the automated means using 2-8 nmol 
amounts. The smaller peptides obtained from the enzymatic digestions 
were subjected to the manual method of 4-N,N-dimethyl- 
aminoazobenzene-4’-isothiocyanate (DABITC)/phenylisothiocyanate 
(PITC) double coupling microsequencing [12] using 10-25 nmol. 
2.2.5. Amino acid analysis 
Samples of the reduced and Scarboxymethylated protein and the 
various peptides were hydrolyzed with 5.6 M HCl containing 0.02% 
(v/v) cresol at 108°C for 24 h. The amino acids in the hydrolyzates 
were derivatized with PITC and analyzed by HPLC using the Waters 
Pica-Tag method [13]. The presence of free cysteine residues in the 
native protein was examined in 8 M urea by the method of Ellman 
[14,15]. 
2.2.6. Sequence comparisons 
The amino acid sequence of the thrombin-like nzyme/gyroxin ana- 
logue was compared with those of other proteins stored in the PIR- 
International Protein Sequence Database (1990) by computer analysis 
using the FASTA/RDFZ. programmes [16]. Sequence alignments were 
also obtained by using the CLUSTAL program [17]. 
3. RESULTS AND DISCUSSION 
The amino acid sequence of the thrombin-like en- 
zyme/gyroxin analogue from the venom of Lachesis 
muta muta determined by both automated and manual 
sequencing methods is shown in Fig. 1. 
The molecular weight calculated from the sequence 
is 25,656 which is much lower than the values of 41-47 
kDa estimated by SDS-PAGE [5]. However, this is not 
surprising since it was previously demonstrated by neu- 
raminidasc treatment hat the protein is extensively gly- 
cosylated [5], and four putative sites of N-linked glyco- 
sylation, at residues 45, 8 1, 145 and 224 were revealed 
during the present work by blank cycles of sequencing 
in these positions where an ASx was indicated by the 
results of amino acid analysis and the positions were 
followed by the sequence -X-Ser/Thr. The other throm- 
bin-like enzymes from snake venoms show considerable 
variation in their carbohydrate contents, with ancrod 
the a-fibrinogenase from the Malayan pit viper (Agki- 
strodon rhodostoma) containing five putative sites of 
N-linked glycosylation [18], whilst there are two identi- 
fied sites in batroxobin from Bothrops atrax moojeni 
[19,20], but flavoxobin from the habu snake (Trimere- 
surusflavoviridis) does not contain carbohydrate [21]. 
The sequence of the first 25 amino acids at the N- 
terminal was found to be identical with that reported 
previously for the gyroxin analogue from L. muta muta 
[6]. Alignments of the amino acid sequence of the Lach- 
esis muta muta thrombin-like enzyme with those of 
other proteins from snake venom are shown in Fig. 2. 
Comparison of complete sequences reveals that the 
Lachesis protein is most similar with the thrombin-like 
coagulant enzymes flavoxobin (61% sequence identity) 
[21], batroxobin (62% identity) [19,20] and ancrod (63% 
identity) [18]. It is noteworthy that all of these enzymes 
like the Lachesis protein release only fibrinopeptide A 
in the conversion of fibrinogen to fibrin [5,9]. On the 
other hand, the Lachesis protein has only 29% sequence 
identity with bovine thrombin [22] which releases both 
fibrinopeptides A and B from fibrinogen and activates 
factor XIII. 
It can also be seen that the Lachesis protein has 57% 
homology with a factor V cleaving serine esterase from 
the venom of the Russell’s viper (Vipera russelli) [23], 
65% sequence identity amongst the 122 amino acids 
which can be compared with the known fragments of 
the thrombin-like crotalase from the eastern diamond- 
back rattlesnake (Crotalus adamanteus) [24,25], 7 1% 
identity with the 77 amino acids known for catroxobin 
from Crotalus atrox [26], 78% homology in a compari- 
son with the N-terminal 36 amino acids of a kallikrein- 
like enzyme from the prairie rattlesnake (Crotalus viridis 
viridis) [27], 80% identity in the first 30 residues with the 
gyroxin from the South American rattlesnake (Crotalus 
durissus terrijicus) [6] and 58% similarity with the N- 
terminus of the gabonase from Bitis gabonica [28]. 
There is also some homology evident with the other 
serine proteinases, bovine trypsin (37%) [29] and human 
kallikrein (33%) [30]. This homology facilitates the iden- 
tification of the probable catalytic triad of amino acids 
in the Luchesis thrombin-like protein as His43, AspE8 
and Ser”‘. As might be expected these amino acids 
occur in regions of the sequences which are more highly 
conserved. 
As no free cysteine residue was detected in the 
Lachesis protein by the Ellman reaction, it may be 
presumed that the 12 cysteine residues in the sequence 
are all involved in the formation of six disulphide 
bridges. 
117 
Volume 329, number 1,2 FEBSLETTERS 
1 10 20 30 
V-I-G-G-D-E-C-N-I-N-E-H-R-F-L-V-A-L-Y-D-G-L-S-G-T-F-L-C-G-G-T-L-I- 
777777777777177777777777777777777 
. L 
<________-p-_--w-__- ><---___p____ ><__p__ ,<...-pm- > <---p--- ><- 
<_________-__E_________-- <_____~~~___~_~><________E--______~ 
<_________-_c__________-_- > <____-_~___--_ > <- 
40 * 50 60 
N-Q-E-W-V-L-T-A-Q-H-C-N-R-S-L-M-N-I-Y-L-G-M-H-N-K-N-V-K-F-D-D-E-Q- 
777 7777 7777-i 77777777 7777777 
< IB 
<_----_V--_---- <--------T------- ><-T- ><-----T-s- 
_p--.. <--___--___p___-__-___-__><-----___p---__~- ><----_-_-_-_ 
<___--____~________--><---_--____-__ ><__---___E__ 
__c--- > <____--_~_----__ > 
70 80 * 90 
R-R-Y-P-K-K-K-Y-F-F-R-C-N-K-N-F-T-K-W-D-E-D-I-R-L-N-R-P-V-R-F-S-A- 
4 IB 
-><--T---> <--T---,<-T- ><--TV- ><---~T~--~~><~~~~T~~-~~><----- 
__________-______><-____--_____p___________><________________p~__~ 
_________-___><-______- ~_________><__-_____~_____E--_~~~~______--~ > 
<_-___c____><____c____ ><_-_-_ 
100 110 120 130 
H-I-E-P-L-S-L-P-S-N-P-P-S-E-D-S-V-C-R-V-M-G-W-G-Q-I-T-S-P-P-E-T-L- 
i IB- 
~~~~-T~~~--~--~-~~~~~~--~~~~~-----~~-> < CN 
_________-_ ><__-___~~~p~~______~ <---__________~p~~____-~--~_ > 
<-w-E-- ><______---_E_---_____ ><-E- ><----Es--- ><----E---- ><- 
__c_---_ ><______________c__-______---__ > <_______---__~_____- 
140 * 150 160 
P-D-V-P-H-C-A-N-I-N-L-F-N-Y-T-V-C-R-G-A-Y-P-R-N-P-~-K-V-L-C-A-G-V- 
<---T----><--T-- ,<--------T-m 
________-p__-_______ ><___p____- ><________p____________ ><___p_-- 
-----E------ ><------E------ ><~~K-~-><-~~~~~~~~~~~- 
____.“___-><____c-___ > <___---_____c--__--_______ ><----_--_-_ 
170 180 190 
L-E-G-G-I-D-T-C-N-R-D-S-G-G-P-L-I-C-N-G-Q-F-Q-G-K-V-F-W-G-P-D-P-C- 
-IB- 
~~~-~--~----~-~-~_~><~~~~~____T_~~~_____-~~ > 
><--p-v- <---_--__p----_-__ ><--_--p-_--- <-----_-__p_ 
<___-__-E-_-_-_ <~~~~~~,<~~~------E--- 
____-c--___----______________ ><____~__-- > <___-_--__-____ 
< HA 
200 210 220 * 
A-Q-P-D-K-P-G-V-Y-T-K-V-F-D-Y-L-D-W-I-Q-S-V-I-A-G-N-T-T-C-S 
-1B > 
<~~~~~~~--~-~-_-T-----_-~~~ 
______________ ><_--__p__- ><:-__p_- <_-______p________-> 
<----------E----_--a- ><_...___----E-_----- ><____--E _----_-_-_> 
_____c_-----_-_-_><__c__ ><__-c___ ><___-_____c______-_____> 
August 1993 
Fig. 1. The amino acid sequence of the thrombin-likefgyroxin analogue from the venom of the bushmaster snake (.&ache& mum mu@. Arrows 
(-) indicate residues determined by automated egradation of the intact s-reduced and carboxymethylated protein. Solid lines indicate fragments 
derived from chemical cleavages with iodosobenzoic acid (IB), cyanogen bromide (CN) or hydroxylamine (HA) which were sequenced by the 
automatic method. Dotted lines indicate peptides from enzymatic digestions with trypsin (T), pepsin (P), elastase (E) and chymotrypsin (C) which 
were sequenced by the manual DABITCIPITC method. Asterisks (*) show sites of N-linked glycosylation. 
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1 Lmm 
2 Ant 
3 Fla 
4 Bat 
5 Rvv 
6 Bth 
7 Btr 
a Hka 
9 Cro 
10 Cat 
11 Gab 
12 Ckl 
13 Gyr 
10 20 30 40 50 
VIGGDECNINEHRFLVALYDLSG-TFLCGGTLINQEWVL-----NI 
VIGGDECNINEHRFLVAVYEGT~FICGGVLIHPE~ITAEHC~-------~-----NL 
VIGGDECNINEHPFLVALYDAWSG-RFLCGGTLINPEWVL-----K- 
VIGGDECDINEHPFL-AF-MYYSP-RYFCGMTLINQEWVL------F-M-----RI 
WGGDECNINEHPFLVALYTSTSS-TIHCGGALINREWVL-------NI-----RI 
IVEGQDAEVGLSPWQVMLFRSPQ-ELLCGASLISDRWVLI 
IVGGYTCGANTVPYQVSLQ--- SG-YHFCGGSLINSQWWSAAHC-----YKSGIGV-----R- 
IVGGT~WGEWPWQVSLQ~LTAQ~LCGGSLIGHQ~LT~HCFDG--LPLQD~-----RI 
VIGGDECNINEHRFLVALYDYWXQ-XFL 
WGGDECNINEHRSLVAIFV--STE-FDCGGDLINVEWVLTAAHC 
WGGAECKIDGHRCLALLY 
VIGGDECNINEHRFLVALYDP-DG--FLSGGILLNEE 
VIGGDECNINEHNFLVALYEYWS-ESFLCGG 
* * * ** * ** 
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YLGMHNKNVKFDDEQRRYPKKKYFFRC-NK-~KWDEDI---~NRP~FS~IEPLSLPSNPPS--- 
VFGMHRHSEKFDDEQERYPKYFIRC-~-RTSWDEDI~I~KP~EHIAPLSLPSNPPI--- 
-LGAHSQKVLNEDEQIRNPKEKFI--CPNKKNTEVLDKDIMLIKLDSPVSYSEHIAPLSLPSSPPS--- 
HLGKHAGSVANYDEWRYPKEKFI--CPNKKKNVITDRDIMSEHIAPLSLPSNPPS--- 
KLGMHSKNIRNEDEQIRVPRGKYF--CLNTKFPNGLDKDI~IRL~P~YSTHIAPVSLPSRSRG--- 
--GKHSRTRYERKVEKISHKIYIH-PRYNWKENLDRDIL 
-LGQDNINWEGNQQFISASKSIV-H-PSYN-SNTLNWDIMSISLPTSCAS--- 
YSGIL~DITKDTPFSQIKEIII-H-QNYKVSEG-NHDI~IKLQAPL~EFQKPICLPSKGDTST- 
RSVQFDKEQQR DKDIMLIRLNKPVSYSEHIAPLSLPSSPPI 
* ** * ** 
120 130 140 150 160 
EDSVC--RVMGWGQITS--PPET-LPDVPHC~INL--F~CRGAYP~-P-T~CAGVL--EGG- 
VGSDC--RVMGWGSINR--RIDV-LSDEPRCANINL--H~CHGL~PKKGRVLCAGDL--RGR- 
VGSVC--RIMGWGSITP--VEET-FPDVPHCANINL--LDDVECKPGYPELLPEYRTLCAGVL--QGG- 
VGSVC--RIMGWGAITT--SEDT-YPDVPHC~INL--F~CR~YNGL-P-~TLCAGVL--QGG- 
VGSRC--RIMGWGKIST--TEDT-YPDVPHCTNIFI--VKLCAGIL--KGG- 
LHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQWNLPLVER 
AGTQC--LISGWGNTKS--SGTS-YPDVLKCLKA-_PILSKSAYPGQITSN-MFCAGYL--EGG- 
IYTNC--WVTGWGFSKE--KGEI-QNILQKV-NI-_PLVTCAGYK--EGG- 
VGSVC--RAMGWGQTTS--PQET-LPDVPHCANINL--LDYEVC 
TLCAGI-P-EGG- 
*** * *** * 
180 190 200 210 220 
IDTCNRDSGGPL--IC--NGQFQ--GIVFWGPDPCAQPDKPGVYTKVFDYLDWIQSVIAG~--CS 
RDSCNSDSGGPL--IC--NEELH--GIVARGPNPCAQPNPCAQPNKPALYTSIYNYRD~~IAG~--CSP 
IDTCGFDSGTPL--IC--NGQFQ--GIWIGSHPCGQSRKPCLP 
IDTCGGDSGGPL--IC--NGQFQ--GILSWGSDPCAEPRITC-P 
RDTCHGDSGGPL--IC--NGQIQ--GIVAGGSEPCGQHLKCPP 
GDACEGDSGGPFVMXSPYN~WYQMGIVSWG-EGCDRNGKIDRLGS 
KDSCQGDSGGPV--VC--SGKLQ--GIVSWG-SGCAQKWKYVSWIKQTIASN 
KDACKGDSGGPL--VCKHNGMWRLVGITSWG-EGCARREQSPA 
CDCKEKYFDCWNTFKED 
LDTCGGDSGGPL--IC--DGKPD--GITS 
** *** * ** * * * 
Fig. 2. Comparison of the amino acid sequences of (1) the thrombin-like enzyme/gyroxin analogue from the bushmaster snake (Lachesis mutu muta) 
(Lmm), with (2) ancrod (Ant) from the Malayan pit viper (Agkistrodon rhodostomu) [18], (3) the flavoxobin (Fla) from the habu snake (Trimeresurus 
jfuvoviridis) [21], (4) batroxobin (Bat) from Bothrops atrox moojeni [19,20], (5) a factor V cleaving serine esterase (Rvv) from the Russell’s viper 
(Vipera russelli) [23], (6) bovine thrombin (Bth) [22], (7) bovine trypsin (Btr) [29], (8) human kallikrein (Hka) [30], (9) fragments of crotalase (Cro) 
from the eastern diamondback rattlesnake (Crolulus udamuntew) [24,25], (10) fragments of catroxobin (Cat) from Crotalus utrox [26], (11) 
N-terminal sequence of the gabonase from Bitis gubonicu [28], (12) N-terminal of a kallikrein-like nzyme (Ckl) from the prairie rattlesnake (Crotulus 
viridis viridis) [271 and (13) gyroxin from the South American rattlesnake (Crotulus durissus ter@icw) [6]. Gaps (-) are inserted in the 
sequences to maximize homology. Potential sites of N-linked glycosylation are underlined. Asterisks (*) show residues which are invariant in all 
sequences. 
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